SEPTIN9 and colorectal carcinoma: The results obtained by Song et al. (2018) and He et al. (2018) suggest that the methylation status of SEPT9 could be applied to CRC stage, size, invasion depth, future risk assessment, metastasis, disease progression monitoring, and therapeutic effect evaluation.